CD93 and melanoma: CD93 deficiency in melanoma-bearing mice was associated with reduced endothelial barrier function in the primary tumor, enhanced expression of MMP9, and increased metastatic spread, which was reversed to wild-type levels when VEGFR2 signaling was inhibited.